FDA Adverse Event Injury Summary report: N

TAXUS® LIBERTÉ®

MDR report key: 2905049 · Received January 9, 2013

Report

Report Number
2134265-2012-08327
Event Type
Injury
Date Received
January 9, 2013
Date of Event
December 24, 2011
Report Date
December 13, 2012
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
NIQ
PMA / PMN Number
P060008
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS A COMBINATION PRODUCT.(B)(4). DEVICE EVALUATED BY MANUFACTURER - IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. THE MANUFACTURING BATCH RECORD REVIEW CONFIRMED THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE ROOT CAUSE IS ANTICIPATED PROCEDURAL COMPLICATIONS AS THIS EVENT IS A KNOWN PHYSIOLOGICAL EFFECT OF THE PROCEDURE AND IS NOTED WITHIN THE DFU.(B)(4).

Description of Event or Problem · 1

(B)(6) CLINICAL STUDY. IT WAS REPORTED THAT POST A CORONARY STENTING TREATMENT PROCEDURE, THE PATIENT EXPERIENCED VENTRICULAR FIBRILLATION. IN (B)(6) 2010, THE PATIENT PRESENTED WITH STABLE ANGINA. THE TARGET LESION WAS A LONG BIFURCATION LESION LOCATED IN THE LEFT MAIN CORONARY ARTERY (LMCA) EXTENDING INTO THE PROXIMAL LEFT ANTERIOR DESCENDING (LAD). THE LESION WAS 90% STENOSED, 4.0MM IN DIAMETER AND 10MM LONG. THE LESION WAS TREATED WITH PREDILATION AND PLACEMENT OF A 4.0X12MM TAXUS LIBERTE STENT. FOLLOWING POST DILATION USING KISSING BALLOON TECHNIQUE, RESIDUAL STENOSIS WAS 0%. THE PATIENT WAS DISCHARGED ON ASPIRIN AND PRASUGREL. IN (B)(6) 2011, THE PATIENT PRESENTED WITH VENTRICULAR FIBRILLATION AND WAS HOSPITALIZED ON THE SAME DAY. THE EVENT WAS CONSIDERED RESOLVED WITHOUT RESIDUAL EFFECT AND THE PATIENT WAS DISCHARGED THREE DAYS LATER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
12544 TAXUS® LIBERTÉ® CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - MAPLE GROVE H7493893612400 0013170933

Patients

Seq Age Sex Outcome Treatment
1 66 YR Hospitalization